Research location

Empoli

Italy

Published trials9

Site observations9

Linked trials published9

Page1 / 1

Research activity in Empoli

Italy

CureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Empoli

9 linked trials · page 1 of 1

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)NCT06103864 · 2023-11-23 · 1 site observation

DESTINY Breast Respond HER2-(Ultra)Low EuropeNCT05945732 · 2023-10-24 · 1 site observation

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System PacingNCT06324682 · 2023-01-01 · 1 site observation

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerNCT06112379 · 2023-11-14 · 1 site observation

ACTIVE_NOT_RECRUITING

Selection of Potential Predictors of Worsening Heart FailureNCT01836510 · 2012-05-01 · 1 site observation

Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative DiseasesNCT01384825 · 2010-12-01 · 1 site observation

A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple SclerosisNCT01047319 · 2010-05-27 · 1 site observation

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)NCT00605215 · 2008-04-24 · 1 site observation

Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With SchizophreniaNCT00139737 · 2002-03-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.